Literature DB >> 8548661

snRNA interactions at 5' and 3' splice sites monitored by photoactivated crosslinking in yeast spliceosomes.

A J Newman1, S Teigelkamp, J D Beggs.   

Abstract

Splice site recognition and catalysis of the transesterification reactions in the spliceosome are accompanied by a dynamic series of interactions involving conserved or invariant sequences in the spliceosomal snRNAs. We have used site-specific photoactivated crosslinking in yeast spliceosomes to monitor interactions between snRNAs and exon sequences near the 5' and 3' splice sites. The last nucleotide of the 5' exon can be crosslinked to an invariant loop sequence in U5 SnRNA before and after 5' splice site cleavage. The first nucleotide of the 3' exon can also be crosslinked to the same U5 loop sequence, but this contact is only detectable after the first transesterification. These results are in close agreement with earlier data from mammalian splicing extracts, and they are consistent with a model in which U5 snRNA aligns the 5' and 3' exons for the second transesterification. After the first catalytic step of splicing, the first nucleotide of the 3' exon can also crosslink to nt U23 in U2 snRNA. This is one of a cluster of residues in U2-U6 helix I implicated by mutational analysis in the second catalytic step of splicing. The crosslinking data suggest that these residues in U2-U6 helix I are in close proximity to the scissile phosphodiester bond at the 3' splice site prior to the second transesterification. These results constitute the first biochemical evidence for a direct interaction between the 3' splice site and U2 snRNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548661      PMCID: PMC1369345     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  58 in total

1.  Sequences upstream of the branch site are required to form helix II between U2 and U6 snRNA in a trans-splicing reaction.

Authors:  G Ast; T Pavelitz; A M Weiner
Journal:  Nucleic Acids Res       Date:  2001-04-15       Impact factor: 16.971

2.  A tertiary interaction detected in a human U2-U6 snRNA complex assembled in vitro resembles a genetically proven interaction in yeast.

Authors:  S Valadkhan; J L Manley
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

3.  Conserved loop I of U5 small nuclear RNA is dispensable for both catalytic steps of pre-mRNA splicing in HeLa nuclear extracts.

Authors:  V Ségault; C L Will; M Polycarpou-Schwarz; I W Mattaj; C Branlant; R Lührmann
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

4.  A premature termination codon interferes with the nuclear function of an exon splicing enhancer in an open reading frame-dependent manner.

Authors:  A Gersappe; D J Pintel
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

6.  Identification of a U2/U6 helix la mutant that influences 3' splice site selection during nuclear pre-mRNA splicing.

Authors:  J S Chang; D S McPheeters
Journal:  RNA       Date:  2000-08       Impact factor: 4.942

7.  Genetic interactions between the 5' and 3' splice site consensus sequences and U6 snRNA during the second catalytic step of pre-mRNA splicing.

Authors:  C A Collins; C Guthrie
Journal:  RNA       Date:  2001-12       Impact factor: 4.942

8.  ATP-dependent interaction of yeast U5 snRNA loop 1 with the 5' splice site.

Authors:  R K Alvi; M Lund; R T Okeefe
Journal:  RNA       Date:  2001-07       Impact factor: 4.942

9.  Proximity of the invariant loop of U5 snRNA to the second intron residue during pre-mRNA splicing.

Authors:  T S McConnell; J A Steitz
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

10.  Genetic and functional interaction of evolutionarily conserved regions of the Prp18 protein and the U5 snRNA.

Authors:  Dagmar Bacíková; David S Horowitz
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.